FENFLURAMINE (has an active metabolite) | FENFLURAMINE | ATC A08AA02
NERVOUS SYSTEM TREATMENT OF SEIZURES ASSOCIATED WITH DRAVET SYNDROME INCREASE EXTRACELLULAR LEVELS OF SEROTONIN THROUGH INTERACTION WITH SEROTONIN TRANSPORTER PROTEINS EXHIBIT AGONIST ACTIVITY AT SEROTONIN 5HT-2 RECEPTORS | ORAL | Cmax 294.2 NANOMOLAR Tmax 4.5 HOUR F 71 PERCENT VD 773.5 LITER (65 KILOGRAM) PPB 50 PERCENT Cl 24.8 LITER / HOUR HT 20 HOUR | SEROTONIN TRANSPORTER | Alpha-2C adrenergic receptor P18825 (ADA2C_HUMAN) | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |